Avacta : Christina Coughlin, MD, PhD, appointed Chief Execut

Dr. Coughlin has served as a Director since 2022, assuming the role of Head of Research and Development in February 2024, driving the development of the pre|CISION™ platform


...

Related Keywords

Christina Coughlin , Alastair Smith , Eliot Forster , Pfizer , Novartis , Head Of Research , Avacta Group , Head Of Research Development , University Of Pennsylvania , Chief Executive Officer , Avacta Board , Chief Medical , Chief Executive , Markets ,